Argentum Falters Again On Gilenya As US Supreme Court Says No
Federal Circuit Told Argentum It Lacked Standing To Appeal
The US Supreme Court has denied Argentum Pharmaceuticals’ petition for certiorari review of an unfavorable Federal Circuit decision that considered whether the generics player had the standing to appeal a PTAB ruling.
